Crossject SA
DIJON, I0 · CIK 0002136893 · Medtech · Public
ZENEO needle-free injection platform for delivering pharmaceutical solutions
crossject.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $10M
- 1 Form D · Jun 2026
- 4 months since last filing
- Contracts
- $104M
- 1 award · Health and Human S
- #10 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Advanced Research And Development And Delivery Of Adult And Pediatric Midazolam Autoinjectors That Have Received Emergency Use Authorization (eua) Or Fda Approval For The Treatment Of Status Epilepticus Seizures In Adult And Pediatric Populations (2+ | $104,152,986 | |
| Private capital raised | Form D · SEC | $10,259,936 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 7 | Synchron | $170M | $82M |
| 8 | Foundation Medicine, Inc. | $158M | $59M |
| 9 | Inbios International Inc | $146M | — |
| 10 | Crossject SA | $104M | $10M |
| 11 | Stratatech Corporation | $98M | $3.0M |
| 12 | RAPISCAN LABORATORIES, INC. | $68M | — |
| 13 | SELUX DIAGNOSTICS, INC. | $63M | $124M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Patrick AlexandreDirector · Executive Officer
- Olivier LacombeExecutive Officer
- Isabelle LiebschutzDirector · Executive Officer
- Didier MorinExecutive Officer
- Lionel SeltzExecutive Officer
- Tony TiptonExecutive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.